Stock Financial Ratios

ATHN / athenahealth, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Market Cap ($M)5,513.63
Enterprise Value ($M)5,425.71
Book Value ($M)791.50
Book Value / Share19.45
Price / Book6.97
NCAV ($M)-159.40
NCAV / Share-3.92
Price / NCAV-35.29
Income Statement (mra) ($M)
Net Income53.10
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Quick Ratio1.84
Current Ratio1.84
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.07
Return on Assets (ROA)0.04
Return on Equity (ROE)0.08
Identifiers and Descriptors
Central Index Key (CIK)1131096
Industry Groups
SIC 7389 - Business Services, Not Elsewhere Classified
Other Related CUSIPS
Share Statistics
Weighted Average Number Diluted Shares Outstanding Adjustment800,000
Common Stock Shares Outstanding40,100,000
Weighted Average Number Of Diluted Shares Outstanding40,700,000
Preferred Stock Shares Outstanding0
Common Shares Outstanding40,097,805
Weighted Average Number Of Shares Outstanding Basic39,900,000
Scoring Models
Piotroski F-Score6.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Intangibles Per Share2.67
Cash Per Share0.00
Accounts Payable Per Share0.00
Assets Non Current Per Share0.00
Inventory Per Share0.00
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Other Non Current Per Share0.00
Inventory Work In Progress Per Share0.00
Goodwill Per Share0.00
Property Plant And Equipment Net Per Share0.00
Additional Paid In Capital Per Share0.00
Liabilities Current Per Share0.00
Debt Per Share0.00
Assets Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Equity Per Share0.00
Assets Current Per Share0.00
Minority Interest Per Share0.00

Peers - Business Services, Not Elsewhere Classified (7389)

Related News Stories

Here's Why You Must Add Haemonetics (HAE) to Your Portfolio

7h zacks
Haemonetics Corporation (HAE - Free Report) has been on a healthy growth trajectory of late. Shares of the company have soared 66.2% in the last six months, ahead of the S&P 500 index’s 11% gain. The stock has a market cap of $3.70 billion. Over the past year, this Zacks Rank #1 (Strong Buy) stock has returned 84.5%, compared with the S&P 500 index’s gain of 14.7%. This value is also higher than the broader industry’s 13% rally. (78-0)

Varian (VAR) Acquires Evinance to Boost Oncology Segment

8h zacks
In a bid to overhaul its Oncology Systems segment, Varian Medical Systems, Inc. (VAR - Free Report) recently acquired Montreal-based privately-held Evinance Innovation, Inc. — a clinical decision support (CDS) software company. The deal was initiated last September, wherein Varian had stated that it will utilize Evinance’s patented technology to offer better services to its clients. (81-0)

Cerner Partnering With Surescripts to Revamp EHR Platform

2018-02-22 zacks
Cerner Corporation (CERN - Free Report) announced that it is collaborating with Virginia-based Surescripts, an information technology company that provides network to pharmacies for connecting fragmented health information technology. With this deal, Cerner will be able to integrate Surescripts’ Real-Time Prescription Benefit functionality into the “Cerner Millennium” electronic health record (EHR). (109-0)

Hologic Banks on Diagnostics, GYN Surgical Prospects Bright

2018-02-16 zacks
On Feb 14, we issued an updated research report on Hologic, Inc. (HOLX - Free Report) . The stock carries a Zacks Rank #2 (Buy). (74-0)

Tracking David Einhorn's Portfolio - Q4 2017 Update

2018-02-16 seekingalpha
Greenlight's long/short ratio is at 107% long and 66% short compared to 118% long and 73% short last quarter. (1135-11)

CUSIP: 04685W103